Back to Search Start Over

Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force.

Authors :
Boustani, Malaz
Peterson, Britt
Hanson, Laura
Harris, Russell
Lohr, Kathleen N.
Source :
Annals of Internal Medicine. 6/3/2003, Vol. 138 Issue 11, p927. 16p.
Publication Year :
2003

Abstract

Background: Dementia is a large and growing problem but is often not diagnosed in its earlier stages. Screening and earlier treatment could reduce the burden of suffering of this syndrome. Purpose: To review the evidence of benefits and harms of screening for and earlier treatment of dementia. Data Sources: MEDLINE, PsycINFO, EMBASE, the Cochrane Library, experts, and bibliographies of reviews. Study Selection: The authors developed eight key questions representing a logical chain between screening and improved health outcomes, along with eligibility criteria for admissible evidence for each question. Admissible evidence was obtained by searching the data sources. Data Extraction: Two reviewers abstracted relevant information using standardized abstraction forms and graded article quality according to U.S. Preventive Services Task Force criteria. Data Synthesis: No randomized, controlled trial of screening for dementia has been completed. Brief screening tools can detect some persons with early dementia (positive predictive value ≤ 50%). Six to 12 months of treatment with cholinesterase inhibitors modestly slows the decline of cognitive and global clinical change scores in some patients with mild to moderate Alzheimer disease. Function is minimally affected, and fewer than 20% of patients stop taking cholinesterase inhibitors because of side effects. Only limited evidence indicates that any other pharmacologic or nonpharmacologic intervention slows decline in persons with early dementia. Although intensive multicomponent caregiver interventions may delay nursing home placement of patients who have caregivers, the relevance of this finding for persons who do not yet have caregivers is uncertain. Other potential benefits and harms of screening have not been studied. Conclusions: Screening tests can detect undiagnosed dementia. In persons with mild to moderate clinically detected Alzheimer disease, cholinesterase inhibitors are somewhat effective in... [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00034819
Volume :
138
Issue :
11
Database :
Academic Search Index
Journal :
Annals of Internal Medicine
Publication Type :
Academic Journal
Accession number :
9926304
Full Text :
https://doi.org/10.7326/0003-4819-138-11-200306030-00015